Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1400 of 3546 entries
View as:

Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00774995 Org: User:
Start: 11/30/08 End: 06/30/10 Due: 06/30/11

Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion

Phase: N/A Priority: Normal
NCT ID: NCT02275364 Org: User:
Start: 08/05/13 End: 10/30/13 Due: 10/30/14

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01310413 Org: User:
Start: 03/07/11 End: 01/26/14 Due: 01/26/15

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03843359 Org: User:
Start: 03/12/19 End: 03/31/25 Due: 03/31/26

Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212

Phase: N/A Priority: Normal
NCT ID: NCT01387204 Org: User:
Start: 02/15/11 End: 07/18/11 Due: 07/18/12

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years

Phase: N/A Priority: Normal
NCT ID: NCT00719043 Org: User:
Start: 07/11/08 End: 02/18/11 Due: 02/18/12

Asthma Exacerbation Study

Phase: N/A Priority: Normal
NCT ID: NCT01086384 Org: User:
Start: 02/22/10 End: 09/15/11 Due: 09/15/12

Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00779766 Org: User:
Start: 10/22/08 End: 02/28/16 Due: 02/28/17

The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT02612064 Org: User:
Start: 11/01/15 End: 06/03/16 Due: 06/03/17

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04151225 Org: User:
Start: 04/05/21 End: 05/26/25 Due: 05/26/26

Twinrix Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT03619590 Org: User:
Start: 05/18/01 End: 09/15/17 Due: 09/15/18

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

Phase: N/A Priority: Normal
NCT ID: NCT00537719 Org: User:
Start: 12/07/07 End: 04/04/08 Due: 04/04/09

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

Phase: N/A Priority: Normal
NCT ID: NCT00291343 Org: User:
Start: 02/01/06 End: 03/15/07 Due: 03/15/08

To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.

Phase: N/A Priority: Normal
NCT ID: NCT00426608 Org: User:
Start: 10/06/06 End: 01/08/07 Due: 01/08/08

Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00358813 Org: User:
Start: 09/08/06 End: 08/22/08 Due: 08/22/09

GSK2251052 Mass Balance in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01475695 Org: User:
Start: 04/21/11 End: 05/19/11 Due: 05/19/12

Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag

Phase: N/A Priority: Normal
NCT ID: NCT01147809 Org: User:
Start: 06/30/10 End: 03/31/15 Due: 03/31/16

IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01587742 Org: User:
Start: 11/30/11 End: 08/31/14 Due: 08/31/15

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02799784 Org: User:
Start: 07/14/16 End: 04/27/17 Due: 04/27/18

Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02639351 Org: User:
Start: 03/01/16 End: 08/31/17 Due: 08/31/18

To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste

Phase: N/A Priority: Normal
NCT ID: NCT02207907 Org: User:
Start: 08/31/14 End: 03/31/15 Due: 03/31/16

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT04179032 Org: User:
Start: 11/28/19 End: 04/23/27 Due: 04/23/28

A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.

Phase: N/A Priority: Normal
NCT ID: NCT00783549 Org: User:
Start: 09/04/08 End: 03/31/09 Due: 03/31/10

Long-term Safety Study for GSK573719/GW642444 in Japanese

Phase: N/A Priority: Normal
NCT ID: NCT01376388 Org: User:
Start: 08/31/11 End: 12/31/12 Due: 12/31/13

Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults

Phase: N/A Priority: Normal
NCT ID: NCT01086449 Org: User:
Start: 03/04/10 End: 11/25/10 Due: 11/25/11